MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
Canada1 1.22%
United States13 56.17%
Denmark1 4.85%
France1 5.00%
Ireland2 4.47%
Netherlands1 4.97%
Switzerland1 5.29%
United Kingdom3 10.10%
Israel1 3.46%
Japan1 4.46%
Total25 100.00%
SectorComponentsWeight
Health Care25 100.00%
Total25 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap2,797,287,421,000 USD21 96.34%
Mid-Cap11,665,274,900 USD3 3.43%
Small-Cap571,302,460 USD1 0.23%
Micro-Cap---
Total2,809,523,998,360 USD25 100.00%
Up